Doxorubicin-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition by ICRF-187

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 9, 1996, Pages 1931-1943

  Zhang, Jun ^a   Clark Jr , John R ^b   Herman, Eugene H ^a   Ferrans, Victor J ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Apoptosis; Cardiomyopathy; Doxorubicin toxicity; ICRF 187; Nephropathy

Indexed keywords

DOXORUBICIN; RAZOXANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG CYTOTOXICITY; ENDOTHELIUM CELL; EPITHELIUM CELL; HEART; HEART PROTECTION; INTESTINE; INTESTINE EPITHELIUM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRON CHELATION; KIDNEY; KIDNEY EPITHELIUM; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALIA; STAPHYLOCOCCUS PHAGE 187;

EID: 0030248675     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0186     Document Type: Article

References (47)

1. ABELLO PA, FIDLER SA, BULKLEY GB, BUCHMAN TG, 1994. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch Surg 129: 134-140.
2. ANAND S, VERMA H,, KUMAR L, SINGH N, 1995. Induction of apoptosis in chronic myelogenous leukemia lymphocytes by hydroxyurea and adriamycin. Cancer Lett 88: 101-105.
3. ANILKUMAR TV, SARRAF CE, HUNT T, ALISON MR, 1992. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br J Cancer 552-558.
4. BILLINGHAM ME, 1991. Role of endomyocardial biopsy in diagnosis and treatment of heart disease. In: Silver MD, ed. Cardiovascular Pathology. Churchill Livingstone, New York, 1465-1486.
5. BUTTKE TM, SANDSTROM PA, 1994. Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7-10.
6. COLES HS, BURNE JF, RAFF MC, 1993. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784.
7. CUMMINGS J, ANDERSON L, WILLMOTT N, SMYTH JF, 1991. The molecular pharmacology of doxorubicin in vivo. Eur J Cancer 27: 532-535.
8. DAVIS MA, SMITH MW, CHANG SH, TRUMP BF, 1994. Characterization of a renal epithelial cell model of apoptosis using okadaic acid and the NRK-52E cell line. Toxicol Pathol 22: 595-605.
9. DYPBUKT JM, ANKARCRONA M, BURKITT M, SJOHOM A, STROM K, ORRENIUS S, NICOTERA P, 1994. Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines. J Biol Chem 269: 30553-30560.
10. FORNARI FA, JR., JARVIS WD, GRANT S, ORR MS, RANDOLPH JK, WHITE FK, MUMAW VR, LOVINGS ET, FREEMAN RH, GEWIRTZ DA, 1994. Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin. Cell Growth Differ 5: 723-733.
11. FORREST VJ, KANG YH, MCCLAIN DE, ROBINSON DH, RAMAKRISHNAN N, 1994. Oxidative stress-induced apoptosis prevented by Trolox. Free Radic Biol Med 16: 675-684.
12. GAVRIELI Y, SHERMAN Y, BEN-SASSON SA, 1992. Identification of programmed cell death in-situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 493-501.
13. GIANNI L, MYERS CE, 1992. The role of free radical formation in the cardiotoxicity of anthracycline. In: Muggia FM, Green MD, Speyer JL, eds. Cancer Treatment and the Heart. The John Hopkins University Press, Baltimore, 9-46.
14. GOBE GC, AXELSEN RA, HARMON BV, ALLAN DJ, 1988. Cell death by apoptosis following X-irradiation of the foetal and neonatal rat kidney. Int J Radiat Biol 54: 567-576.
15. GODAR DE, LUCAS AD, 1995. Spectral dependence of UV-induced immediate and delayed apoptosis: the role of membrane and DNA damage. Photochem Photobiol 62: 108-113.
16. GOTTLIEB RA, BURLESON KO, KLONER RA, BABIOR M, ENGLER RL, 1994. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628.
17. HASINOFF BB, KUSCHAK TI, YALOWICH JC, CREIGHTON AM, 1995. A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bis-dioxopiperazine analogs of ICRF-187 (dextrazoxane). Biochem Pharmacol 50: 953-958.
18. HERMAN EH, EL-HAGE AN, FERRANS VJ, ARDALAN B, 1985. Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats. Toxicol Appl Pharmacol 78: 202-214.
19. HERMAN EH, EL-HAGE A, FERRANS VJ, 1988. Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) rats. Toxicol Appl Pharmacol 92: 42-53.
20. HERMAN EH, FERRANS VJ, SANCHEZ JA, 1992. Methods of reducing the cardiotoxicity of anthracyclines. In: Muggia FM, Green MD, Speyer JL, eds. Cancer Treatment and the Heart. The John Hopkins University Press, Baltimore, 114-169.
21. HERMAN EH, ZHANG J, FERRANS VJ, 1994. Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats. Cancer Chemother Pharmacol 35: 93-100.
22. IJIRI K, POTTEN CS, 1987. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 55: 13-123.
23. ISHIDA R, MIKI T, NARITA T, YUI R, SATO M, UTSUMI KR, TANABE K, ANDOH T, 1991. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors. Cancer Res 51: 4909-4916.
24. KLEFER MC, BRAVEUER MJ, POWERS VC, WU JJ, UMANSKY SR, TOMEI LD, BARR PJ, 1995. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 736-739.
25. LAMBERTENGHI-DELILIERS G, ZANON PL, POZZOLI EF, BELLINI O, 1976. Myocardial injury induced by a single dose of adriamycin: an electron microscopic study. Tumori 62: 517-528.
26. LING YH, PRIEBE W, PEREZ-SOLER R, 1993. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 53: 1845-1852.
27. LIU LF, 1989. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58: 351-75.
28. MAXWELL MB, MAKER KE, 1992. Chemotherapy-Induced Myelosuppression. Seminars in Oncology Nursing 3: 113-123.
29. MELLO-FILHO AC, MENEGHINI R, 1991. Iron is the intracellular metal involved in the production of DNA damage by oxygen radicals. Mutat Res 251: 109-113.
30. MERSKI JA, DASKAL I, BUSCH H, 1976. Effects of adriamycin on ultrastructure of nucleoli in the heart and liver cells of the rat. Cancer Res 36: 1580-1584.
31. MUINDI J, SINHA BK, GIANNI L, MYERS C, 1985. Thiol-dependent DNA damage produced by anthracycline-iron complexes. The structure-activity relationships and molecular mechanisms. Mol Pharmacol 27: 356-365.
32. OHMORI T, PODACK ER, NISHIO K, TAKAHASHI M, MIYAHARA Y, TAKEDA Y, KUBOTA N, FUNAYAMA Y, OGASAWARA H, OHIRA T, 1993. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem Biophys Res Commun 192: 30-36.
33. PIERCE GB, PARCHMENT RE, LEWELLYN AL, 1991. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation 46: 181-186.
34. POWIS G, 1991. Toxicity of free radical forming anticancer agents. In: Powis G, Hacker MP, eds. The Toxicity of Anticancer Drugs. Pergamon Press, New York, 106-151.
35. SEHESTED M, JENSEN PB, SORENSEN BS, HOLM B, FRICHE E, DEMANT EJ, 1993. Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl) propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16). Biochem Pharmacol 46: 389-393.
36. SKLADANOWSKI A, KONOPA J, 1993. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem Pharmacol 46: 375-382.
37. SLATER A, NOBEL A, BUSTAMANTE J, KIMLAND M, ORRENIUS S, 1995. Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway to thymocyte apoptosis. Biochem J 306: 771-778.
38. TAKEDA K, YU Z, NISHIKAWA T, TANAKA M, HOSODA S, FERRANS VJ, KASAJIMA T, 1996. Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. J Mol Cell Cardiol 28: 209-215.
39. TANABE K, IKEGAMI Y, ISHIDA R, ANDOH T, 1991. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. Cancer Res 51: 4903-4908.
40. TANAKA M, ITO H, ADACHI S, AKIMOTO H, NISHIKAWA T, KASAJIMA T, MARUMO F, HIROE M, 1994. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75: 426-433.
41. THAKKAR NS, POTTEN CS, 1993. Inhibition of doxorubicin-induced apoptosis in vivo by 2-deoxy-D-glucose. Cancer Res 53: 2057-2060.
42. THAKKARNS, POTTEN CS, 1992. Abrogation of adriamycin toxicity in vivo by cycloheximide. Biochem Pharmacol 43: 1683-1691.
43. UNVERFERTH BJ, MAGORIEN RD, BALCERZAK SP, LEIER CV, UNVERFERTH DV, 1983. Early changes in human myocardial nuclei after doxorubicin. Cancer 52: 215-221.
44. WHITTEMORE ER, LOO DT, COTMAN CW, 1994. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport 5: 1485-1488.
45. WOLFE JT, Ross D, COHEN GM, 1994. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett 352: 58-62.
46. ZALESKIS G, BERLETH E, VERSTOVSEK S, EHRKE MJ, MIHICH E, 1994. Doxorubicin-induced DNA degradation in murine thymocytes. Mol Pharmacol 46: 901-908.
47. ZHANG J, HERMAN EH, FERRANS VJ, 1993. Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187. Am J Pathol 142: 1916-1926.